The Sjögren’s Foundation remains dedicated to the safety of Sjögren’s patients and providing you with the information you need to make important health decisions.
On December 28, 2024, the FDA issued a voluntary recall on three lots (Lot NGS751, NGS757, and NGS762- U.S. lots) of NeilMed NasoGel® Spray for Dry Noses for potential microbial contamination. Microbial contamination can potentially cause respiratory tract infections and other serious health conditions.
This recall does not include their other product NasoGel® Tube for Dry Noses (nasal gel).
The FDA voluntary recall was posted on February 5th, 2025 and NeilMed Pharmaceuticals has also posted a recall statement on their website as of February 6th, 2025. Their recall notice reads: "Recall Notice: NeilMed is voluntarily recalling NasoGel Spray lots NGS751, NGS757, and NGS762 distributed in 2024 due to potential contamination, which may lead to symptoms similar to the flu. If your product is affected, please email questions [at] neilmed [dot] com (questions[at]neilmed[dot]com) and put NGS-PA in the subject for further instructions."
NeilMed Pharmaceuticals has instructed customers to examine their product and destroy any of the identified lots. The company has also provided that they will refund or product replacement at no cost. If you are affected, you can send proof of destruction of the lots via email at quality [at] neilmed [dot] com (quality[at]neilmed[dot]com).
Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.
- Complete and submit the report Online
- Regular Mail or Fax: Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178
The Sjögren’s Foundation remains dedicated to the safety of Sjögren’s patients and providing you with the information you need to make important health decisions.
On December 28, 2024, the FDA issued a voluntary recall on three lots (Lot NGS751, NGS757, and NGS762- U.S. lots) of NeilMed NasoGel® Spray for Dry Noses for potential microbial contamination. Microbial contamination can potentially cause respiratory tract infections and other serious health conditions.
This recall does not include their other product NasoGel® Tube for Dry Noses (nasal gel).
The FDA voluntary recall was posted on February 5th, 2025 and NeilMed Pharmaceuticals has also posted a recall statement on their website as of February 6th, 2025. Their recall notice reads: "Recall Notice: NeilMed is voluntarily recalling NasoGel Spray lots NGS751, NGS757, and NGS762 distributed in 2024 due to potential contamination, which may lead to symptoms similar to the flu. If your product is affected, please email questions [at] neilmed [dot] com (questions[at]neilmed[dot]com) and put NGS-PA in the subject for further instructions."
NeilMed Pharmaceuticals has instructed customers to examine their product and destroy any of the identified lots. The company has also provided that they will refund or product replacement at no cost. If you are affected, you can send proof of destruction of the lots via email at quality [at] neilmed [dot] com (quality[at]neilmed[dot]com).
Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.